NICE guidelines. The National Institute for Health and Care Excellence, issues help and guidance on many issues relevant to acid reflux treatment available from their site here.

    The community pharmacist

    Common elements of care

    Referral guidance for endoscopy

    Interventions for uninvestigated dyspepsia

    Reviewing patient care

    Interventions for gastro-oesophageal reflux disease (GORD)

    Interventions for peptic ulcer disease

    Interventions for functional dyspepsia

    Helicobacter pylori testing and eradication

    Laparoscopic fundoplication

    Referral to a specialist service

    Surveillance for people with Barrett's oesophagus

And includes an options grid to help patients and healthcare professionals talk about options for treating heartburn that lasts longer than 4 weeks. (Downloadable at the bottom of this page.)

Further Dyspepsia guidelines are expected to be published in July 2015,
 
Much interest is being shown in new treatment options. Read NICE guidelines on them here:

"Current evidence on the efficacy of endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia is adequate provided that patients are followed up in the long term. There are no major safety concerns. Therefore, this procedure may be used in patients with Barrett's oesophagus with low‑grade dysplasia with normal arrangements for clinical governance, consent and audit or research."

"Current evidence on the efficacy and safety of endoscopic radiofrequency ablation for Barrett's oesophagus with no dysplasia is limited in quality and quantity. Therefore, this procedure should only be used in patients with no dysplasia in the context of research."

"The evidence on the safety and efficacy of laparoscopic insertion of a magnetic bead band for gastro-oesophageal reflux disease (GORD) is limited in quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research."

"The evidence on endoluminal gastroplication for gastro-oesophageal reflux disease (GORD) raises no major safety concerns. Evidence from a number of randomised controlled trials (RCTs) shows a degree of efficacy in terms of reduced medication requirement in the short term, but changes in other efficacy outcomes are inconsistent and there is no good evidence of sustained improvement in oesophageal pH measurements. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research."

Endostim ("Pacemaker for the Lower Oesophageal Sphincter")

"NICE has been notified about the above procedure and are currently undertaking preliminary investigations, with the aim of assessing whether this procedure falls within the remit of the Interventional Procedures Programme."

Ċ
Chris Robinson,
4 Jun 2015, 10:45